These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 11546559

  • 1. Purification and characterization of nuclear type II [(3)H]estradiol binding sites from the rat uterus: covalent labeling with [(3)H]luteolin.
    Markaverich BM, Shoulars K, Brown MA.
    Steroids; 2001 Sep; 66(9):707-19. PubMed ID: 11546559
    [Abstract] [Full Text] [Related]

  • 2. Preliminary assessment of luteolin as an affinity ligand for type II estrogen--binding sites in rat uterine nuclear extracts.
    Markaverich BM, Gregory RR.
    Steroids; 1993 Jun; 58(6):268-74. PubMed ID: 8212072
    [Abstract] [Full Text] [Related]

  • 3. Nuclear binding of the estrogen receptor: heterogeneity of sites and uterotropic response.
    Clark JH, Markaverich B, Upchurch S, Eriksson H, Hardin JW.
    Adv Exp Med Biol; 1979 Jun; 117():17-46. PubMed ID: 474276
    [Abstract] [Full Text] [Related]

  • 4. Preliminary characterization and partial purification of rat uterine nuclear type II Binding sites.
    Markaverich BM, Gregory RR.
    Biochem Biophys Res Commun; 1991 Jun 28; 177(3):1283-90. PubMed ID: 2059216
    [Abstract] [Full Text] [Related]

  • 5. Identification of nuclear type II [(3)H]estradiol binding sites as histone H4.
    Shoulars K, Brown T, Alejandro MA, Crowley J, Markaverich BM.
    Biochem Biophys Res Commun; 2002 Sep 06; 296(5):1083-90. PubMed ID: 12207884
    [Abstract] [Full Text] [Related]

  • 6. Nuclear type II [3H]estradiol binding sites: a histone H3-H4 complex.
    Shoulars K, Rodrigues MA, Crowley JR, Turk J, Thompson T, Markaverich BM.
    J Steroid Biochem Mol Biol; 2005 Jun 06; 96(1):19-30. PubMed ID: 15878266
    [Abstract] [Full Text] [Related]

  • 7. Characterization and partial purification of an estrogen type II binding site in chick oviduct cytosol.
    Densmore CL, Markaverich BM, O'Malley BW, Clark JH.
    Biochemistry; 1989 Sep 19; 28(19):7788-96. PubMed ID: 2611214
    [Abstract] [Full Text] [Related]

  • 8. Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type I and type II sites by [3H]estradiol exchange.
    Markaverich BM, Williams M, Upchurch S, Clark JH.
    Endocrinology; 1981 Jul 19; 109(1):62-9. PubMed ID: 7238414
    [Abstract] [Full Text] [Related]

  • 9. Preliminary characterization of an endogenous inhibitor of [3H]estradiol binding in rat uterine nuclei.
    Markaverich BM, Roberts RR, Finney RW, Clark JH.
    J Biol Chem; 1983 Oct 10; 258(19):11663-71. PubMed ID: 6619136
    [Abstract] [Full Text] [Related]

  • 10. An endogenous ligand for type II binding sites in normal and neoplastic tissues.
    Clark JH, Markaverich BM.
    Adv Exp Med Biol; 1986 Oct 10; 196():305-15. PubMed ID: 3716924
    [Abstract] [Full Text] [Related]

  • 11. Unique molecular properties of a urea- and salt-stable DNA-binding estrogen receptor dimer covalently labeled with the antiestrogen [3H]desmethylnafoxidine aziridine. A comparison with the estrogen-receptor complex.
    Hutchens TW, McNaught RW, Yip TT, Suzuki T, Li CM, Besch PK.
    Mol Endocrinol; 1990 Feb 10; 4(2):255-67. PubMed ID: 2330004
    [Abstract] [Full Text] [Related]

  • 12. Estradiol receptor of calf uterus: interactions with heparin-agarose and purification.
    Molinari AM, Medici N, Moncharmont B, Puca GA.
    Proc Natl Acad Sci U S A; 1977 Nov 10; 74(11):4886-90. PubMed ID: 270721
    [Abstract] [Full Text] [Related]

  • 13. Bioflavonoid interaction with rat uterine type II binding sites and cell growth inhibition.
    Markaverich BM, Roberts RR, Alejandro MA, Johnson GA, Middleditch BS, Clark JH.
    J Steroid Biochem; 1988 Nov 10; 30(1-6):71-8. PubMed ID: 3386279
    [Abstract] [Full Text] [Related]

  • 14. Partial purification and characterization of methyl-p-hydroxyphenyllactate esterase in rat uterine cytosol.
    Maybruck WM, Markaverich BM.
    Steroids; 1997 Mar 10; 62(3):321-30. PubMed ID: 9071742
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
    Attardi B, Happe HK.
    Endocrinology; 1986 Aug 10; 119(2):904-15. PubMed ID: 3732150
    [Abstract] [Full Text] [Related]

  • 16. Analysis of binding of [3H]Estradiol to the cytosol fraction of rat pancreas: comparison with sites in the cytosol of uterus.
    Boctor AM, Band P, Grossman A.
    Endocrinology; 1983 Aug 10; 113(2):453-62. PubMed ID: 6872936
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Estrogen-binding proteins of calf uterus. Purification to homogeneity of receptor from cytosol by affinity chromatography.
    Sica V, Bresciani F.
    Biochemistry; 1979 May 29; 18(11):2369-78. PubMed ID: 444462
    [Abstract] [Full Text] [Related]

  • 20. Estrogen and antiestrogen binding to rat uterine and pituitary estrogen receptor: evidence for at least two physicochemical forms of the estrogen receptor.
    Jasper TW, Ruh MF, Ruh TS.
    J Steroid Biochem; 1985 Nov 29; 23(5A):537-45. PubMed ID: 4079371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.